INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Long Term Provisions History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹0.05 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.03 Cr |
What is the latest Long Term Provisions ratio of INDO US BIOTECH ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹0.05 Cr |
| Mar2024 | ₹0.04 Cr |
| Mar2023 | ₹0.04 Cr |
| Mar2022 | ₹0.04 Cr |
| Mar2021 | ₹0.03 Cr |
How is Long Term Provisions of INDO US BIOTECH Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.05 Cr | 15.91 | |
| Mar2024 | ₹0.04 Cr | 2.33 | |
| Mar2023 | ₹0.04 Cr | 19.44 | |
| Mar2022 | ₹0.04 Cr | 16.13 | |
| Mar2021 | ₹0.03 Cr | - | |
Compare Long Term Provisions of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹152.9 Cr | -5.5% | -11% | -45.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,559.6 Cr | -4.5% | -10.4% | -40.2% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,354.1 Cr | -1.4% | 9.3% | 12.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,306.0 Cr | -7% | -3% | 13% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹894.0 Cr | -6.7% | -2.7% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹514.8 Cr | -1% | 6.7% | -2% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -5.5% |
-11% |
-45.8% |
| SENSEX | -1.6% |
-4.7% |
-8.3% |
You may also like the below Video Courses